Uridine triacetate
| Uridine triacetate | |
|---|---|
| Term | Uridine triacetate |
| Short definition | Uridine triacetate - (pronounced) (YOOR-ih-deen try-A-seh-tayt) medicine used in the emergency treatment of adults and children who are receiving too much fluorouracil or capecitabine, or who have cardiac or central nervous system toxicity, or other serious side effects that occur within 4 days of stopping treatment with these medicines. Uridine triacetate may help protect healthy cells from some of the side effects caused by certain cancer drugs. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Uridine triacetate - (pronounced) (YOOR-ih-deen try-A-seh-tayt) medicine used in the emergency treatment of adults and children who are receiving too much fluorouracil or capecitabine, or who have cardiac or central nervous system toxicity, or other serious side effects that occur within 4 days of stopping treatment with these medicines. Uridine triacetate may help protect healthy cells from some of the side effects caused by certain cancer drugs. It's a type of chemoprotectant and a type of pyrimidine analogue. Also called PN401, Triacetyluridine and Vistogard
External links
- Medical encyclopedia article on Uridine triacetate
- Wikipedia's article - Uridine triacetate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski